REDWOOD CITY, Calif. — Synthego, a leading supplier of CRISPR solutions, has entered a strategic licensing agreement with global biopharmaceutical company AstraZeneca. This agreement grants Synthego a global license to manufacture and distribute AstraZeneca’s novel CRISPR gene editing enzyme, eSpOT-ON, recently published as engineered ePsCas9, to the worldwide research community. This state-of-the-art nuclease, developed by AstraZeneca, will […]
The new Express License service removes barriers to accessing this transformative gene editing technology for startups. An Express License provides fast, simple and affordable access to the CRISPR/Cas9 patent portfolio through a non-exclusive internal research license. DUBLIN and CHESHIRE, United Kingdom — ERS Genomics (‘ERS’), the CRISPR licensing company, today announces the launch of its […]
QIAcuity digital PCR now offers ability for simultaneous detection of up to 12 targets from one biological sample, a more than two-fold increase from prior capability for up to five targets No instrument hardware changes required for upgraded capability thanks to new QIAcuity Software 3.1 update and launch of QIAcuity High Multiplex Probe PCR Kit […]
MENLO PARK, Calif. — PacBio (NASDAQ: PACB), developer of the world’s most advanced sequencing technologies, and Intus Bio, a leader in microbiome research and discovery, today unveiled GutID, the first commercial human gut health test powered by Intus Bio’s groundbreaking Titan-1 platform and PacBio’s HiFi sequencing technology. By combining Intus Bio’s patented strain-level resolution assay […]
ATCC will provide lab services including immunological and virological assays, and reagent and viral stock preparation to support the Animal Models and Retroviral Vaccines Section within the National Cancer Institute’s Vaccine Branch MANASSAS, Va. — ATCC, the world’s premier biological materials management and standards organization, today announced that it has been awarded a five-year, Indefinite […]
Powered by Elegen’s patented cell-free linear DNA synthesis technology, ENFINIA™ Plasmid DNA slashes lead times from months to weeks at an affordable price. SAN CARLOS, Calif. – Elegen, the leader in next-generation DNA manufacturing, today announced the launch of ENFINIA™ Plasmid DNA, a faster, cost-effective solution for clonal synthesis of long and complex genes. ENFINIA Plasmid […]
Vienna, Austria – Regulatory automation provider Platomics has announced a strategic pilot program with Agilent Technologies Inc. (NYSE: A) to enhance laboratory documentation capabilities for next-generation sequencing (NGS) tests under the European Union’s In Vitro Diagnostic Regulation (IVDR). This collaboration enables Agilent customers to leverage Platomics’ PlatoX® platform for generating comprehensive documentation required for IVDR […]
SAN JOSE, Calif. — In 2024, Complete Genomics, a pioneering genomic sequencing company, expanded its U.S. manufacturing footprint with augmented technology capabilities to diversify its supply chain helping it to continue reliably serving customers with flexible, cost-effective next generation sequencing (NGS) solutions. Expanding U.S. manufacturing capabilities in 2024 and beyond After weathering a year of geopolitical […]
Dr Jose-Carlos Gutiérrez-Ramos is the Chief Science Officer at Danaher Corporation. He has held senior drug discovery roles at Pfizer, Abbvie, and GSK. As CEO and President of Synlogic, he led the company from early drug discovery to clinical stage and public markets He brings a wealth of experience across biotechs and pharmaceutical companies, combined with […]
World’s Most Comprehensive Protein Study Highlights Ultima’s Commitment to Unlocking the Power of Genomics at Scale FREMONT, Calif. — Ultima Genomics, Inc., a developer of an ultra-high throughput next-generation sequencing (NGS) platform, today announced that its UG 100™ was selected as the sequencing platform to enable UK Biobank’s unprecedented protein study, which will be the world’s largest […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
